Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks
- Resource Type
- Article
- Authors
- Kiialainen, Anna; Adamkewicz, Joanne I.; Petry, Claire; Oldenburg, Johannes; Pipe, Steven W.; Young, Guy; Mahlangu, Johnny; Lehle, Michaela; Niggli, Markus; Castaman, Giancarlo; Jiménez-Yuste, Víctor; Shima, Midori; Négrier, Claude; Schmitt, Christophe
- Source
- In Research and Practice in Thrombosis and Haemostasis January 2024 8(1)
- Subject
- Language
- ISSN
- 2475-0379